Breast Cancer | Oncology | Pathology Neoadjuvant Chemotherapy Response in Triple-Negative Apocrine Carcinoma: Comparing Apocrine Morphology, Androgen Receptor, and Immune Phenotypes. July 3, 2024
Oncology | Pathology An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability. March 13, 2024
Immunology | Oncology | Pathology Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types. February 14, 2024
Oncology | Pathology Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer. August 30, 2023